Hubbry Logo
HistopathologyHistopathologyMain
Open search
Histopathology
Community hub
Histopathology
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Histopathology
Histopathology
Histopathology
View on Wikipedia
from Wikipedia
Micrograph showing contraction band necrosis, a histopathologic finding of myocardial infarction (heart attack).

Histopathology (compound of three Greek words: ἱστός histos 'tissue', πάθος pathos 'suffering', and -λογία -logia 'study of') is the microscopic examination of tissue in order to study the manifestations of disease. Specifically, in clinical medicine, histopathology refers to the examination of a biopsy or surgical specimen by a pathologist, after the specimen has been processed and histological sections have been placed onto glass slides. In contrast, cytopathology examines free cells or tissue micro-fragments (as "cell blocks ").

Collection of tissues

[edit]

Histopathological examination of tissues starts with surgery, biopsy, or autopsy. The tissue is removed from the body or plant, and then, often following expert dissection in the fresh state, placed in a fixative which stabilizes the tissues to prevent decay. The most common fixative is 10% neutral buffered formalin (corresponding to 3.7% w/v formaldehyde in neutral buffered water, such as phosphate buffered saline).

Preparation for histology

[edit]
Main article: Histology
Items used for submitting specimens: (Biopsy) wrap, (biopsy) sponge, (tissue processing) cassette and (biopsy) bag.

The tissue is then prepared for viewing under a microscope using either chemical fixation or frozen section.

If a large sample is provided e.g. from a surgical procedure then a pathologist looks at the tissue sample and selects the part most likely to yield a useful and accurate diagnosis - this part is removed for examination in a process commonly known as grossing or cut up. Larger samples are cut to correctly situate their anatomical structures in the cassette. Certain specimens (especially biopsies) can undergo agar pre-embedding to assure correct tissue orientation in cassette & then in the block & then on the diagnostic microscopy slide. This is then placed into a plastic cassette for most of the rest of the process.[citation needed]

Chemical fixation

[edit]
Main article: Fixation (histology)

In addition to formalin, other chemical fixatives have been used. But, with the advent of immunohistochemistry (IHC) staining and diagnostic molecular pathology testing on these specimen samples, formalin has become the standard chemical fixative in human diagnostic histopathology. Fixation times for very small specimens are shorter, and standards exist in human diagnostic histopathology.

Processing

[edit]

Water is removed from the sample in successive stages by the use of increasing concentrations of alcohol.[1] Xylene is used in the last dehydration phase instead of alcohol - this is because the wax used in the next stage is soluble in xylene where it is not in alcohol allowing wax to permeate (infiltrate) the specimen.[1] This process is generally automated and done overnight. The wax infiltrated specimen is then transferred to an individual specimen embedding (usually metal) container. Finally, molten wax is introduced around the specimen in the container and cooled to solidification so as to embed it in the wax block.[1] This process is needed to provide a properly oriented sample sturdy enough for obtaining a thin microtome section(s) for the slide.

Once the wax embedded block is finished, sections will be cut from it and usually placed to float on a water bath surface which spreads the section out. This is usually done by hand and is a skilled job (histotechnologist) with the lab personnel making choices about which parts of the specimen microtome wax ribbon to place on slides. A number of slides will usually be prepared from different levels throughout the block. After this the thin section mounted slide is stained and a protective cover slip is mounted on it. For common stains, an automatic process is normally used; but rarely used stains are often done by hand.[1]

Frozen section processing

[edit]
Main article: Frozen section procedure
There is also the option to make a "touch prep", wherein a glass slide is simply pressed against the tissue and then exposed to a fixative solution. The glass slide can then be stained and examined. This is feasible for an initial evaluation of suspected lymphomas.

An initial evaluation of a suspected lymphoma is to make a "touch prep" wherein a glass slide is lightly pressed against excised lymphoid tissue, and subsequently stained (usually H&E stain) for evaluation under light microscopy. The second method of histology processing is called frozen section processing. This is a highly technical scientific method performed by a trained histoscientist. In this method, the tissue is frozen and sliced thinly using a microtome mounted in a below-freezing refrigeration device called the cryostat. The thin frozen sections are mounted on a glass slide, fixed immediately & briefly in liquid fixative, and stained using the similar staining techniques as traditional wax embedded sections. The advantages of this method is rapid processing time, less equipment requirement, and less need for ventilation in the laboratory. The disadvantage is the poor quality of the final slide. It is used in intra-operative pathology for determinations that might help in choosing the next step in surgery during that surgical session (for example, to preliminarily determine clearness of the resection margin of a tumor during surgery).

Staining of processed histology slides

[edit]
Main types of staining seen on H&E stain.
Main article: Staining

This can be done to slides processed by the chemical fixation or frozen section slides. To see the tissue under a microscope, the sections are stained with one or more pigments. The aim of staining is to reveal cellular components; counterstains are used to provide contrast.

The most commonly used stain in histology is a combination of hematoxylin and eosin (often abbreviated H&E). Hematoxylin is used to stain nuclei blue, while eosin stains the cytoplasm and the extracellular connective tissue matrix of most cells pink. There are hundreds of various other techniques which have been used to selectively stain cells. Other compounds used to color tissue sections include safranin, Oil Red O, congo red, silver salts and artificial dyes. Histochemistry refers to the science of using chemical reactions between laboratory chemicals and components within tissue. A commonly performed histochemical technique is the Perls' Prussian blue reaction, used to demonstrate iron deposits in diseases like Hemochromatosis.[2]

Recently, antibodies have been used to stain particular proteins, lipids and carbohydrates. Called immunohistochemistry, this technique has greatly increased the ability to specifically identify categories of cells under a microscope. Other advanced techniques include in situ hybridization to identify specific DNA or RNA molecules. These antibody staining methods often require the use of frozen section histology. These procedures above are also carried out in the laboratory under scrutiny and precision by a trained specialist medical laboratory scientist (a histoscientist). Digital cameras are increasingly used to capture histopathological images.

Interpretation

[edit]

The histological slides are examined under a microscope by a pathologist, a medically qualified specialist who has completed a recognised training program. This medical diagnosis is formulated as a pathology report describing the histological findings and the opinion of the pathologist. In the case of cancer, this represents the tissue diagnosis required for most treatment protocols. In the removal of cancer, the pathologist will indicate whether the surgical margin is cleared, or is involved (residual cancer is left behind). This is done using either the bread loafing or CCPDMA method of processing. Microscopic visual artifacts can potentially cause misdiagnosis of samples. Scanning of slides allows for various methods of digital pathology, including the application of artificial intelligence for interpretation.

Following are examples of general features of suspicious findings that can be appreciated from low to high magnification on histopathology:

  • Orientation (lowest magnification): In this case oriented by the skin surface (green). A lesion is seen (red) and its demarcation can be discerned (diffuse in this case)
    Orientation (lowest magnification): In this case oriented by the skin surface (green). A lesion is seen (red) and its demarcation can be discerned (diffuse in this case)
  • Architectural pattern of any suspicious cells, in this case nests of cells, as well as components of the intervening stroma.
    Architectural pattern of any suspicious cells, in this case nests of cells, as well as components of the intervening stroma.
  • Cellular arrangement, including crowding and cell polarity (common tendencies among cells at the border, such as elongation or "palisading" in this case). Amount of mitoses can also be appreciated at this level.
    Cellular arrangement, including crowding and cell polarity (common tendencies among cells at the border, such as elongation or "palisading" in this case). Amount of mitoses can also be appreciated at this level.
  • Subcellular features (may need highest magnification)
    Subcellular features (may need highest magnification)

Architectural patterns

[edit]

Major histopathologic architectural patterns include:

  • Nests: islands of cells of similar type.
    Nests: islands of cells of similar type.
  • Acinar or tubular: Each acinus consists of cells that surround a lumen.
    Acinar or tubular: Each acinus consists of cells that surround a lumen.
  • Trabecular, elongated (rod-shaped) groups of cells.
    Trabecular, elongated (rod-shaped) groups of cells.
  • Papillary: Protuberances of epithelioid cells around fibrovascular cores.
    Papillary: Protuberances of epithelioid cells around fibrovascular cores.
  • Micropapillary: Papillary tufts without fibrovascular cores
    Micropapillary: Papillary tufts without fibrovascular cores
  • Fascicular: Generally the same cell type throughout, but some form band-like groups that are aligned in the same direction.
    Fascicular: Generally the same cell type throughout, but some form band-like groups that are aligned in the same direction.
  • Woven or storiform: Elongated cells or nuclei wherein small bundles are aligned in an otherwise haphazard pattern.
    Woven or storiform: Elongated cells or nuclei wherein small bundles are aligned in an otherwise haphazard pattern.
  • Solid: More or less the same cell type throughout, with no spaces between, and no other particular pattern.
    Solid: More or less the same cell type throughout, with no spaces between, and no other particular pattern.
  • Cribriform: Solid with multiple clear spaces.
    Cribriform: Solid with multiple clear spaces.
  • Whorled: Multiple concentric objects, or spiral-shaped
    Whorled: Multiple concentric objects, or spiral-shaped
  • Cartwheel pattern: Center points that radiate cells or connective tissue outward
    Cartwheel pattern: Center points that radiate cells or connective tissue outward

Nuclear patterns

[edit]

Major nuclear patterns include:

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Histopathology

View on Grokipedia
from Grokipedia
Histopathology is the microscopic study of diseased cells and tissues, involving the preparation, , and examination of tissue samples to identify pathological changes and diagnose diseases. It represents a branch of focused on the structural and functional alterations in tissues caused by illness, serving as the gold standard for confirming diagnoses in conditions such as cancer. The process of histopathology begins with tissue collection via biopsy or autopsy, followed by fixation—typically in neutral buffered formalin—to preserve cellular architecture and prevent autolysis. Samples are then dehydrated, embedded in paraffin wax, and sectioned into thin slices (usually 4-5 micrometers thick) using a microtome for mounting on slides. Staining is applied next, with hematoxylin and eosin (H&E) being the most common routine method: hematoxylin stains nuclei blue to highlight DNA, while eosin stains cytoplasm and extracellular matrix pink, enabling visualization of cellular details and tissue organization under light microscopy. Specialized stains, such as periodic acid-Schiff (PAS) for carbohydrates or Masson's trichrome for collagen, may be used to detect specific features like fungi, amyloid, or fibrosis. In clinical practice, histopathologists interpret these slides to assess criteria like cell morphology, mitotic activity, , and invasion, which inform tumor grading, staging, and margins in cases. This analysis is essential for , treatment planning—including decisions on , , or —and forensic investigations, where it helps determine causes of . Variability in interpretation can occur, with studies showing major diagnostic changes in approximately 1% of cases upon second review, underscoring the need for clinical correlation and multidisciplinary input. The foundations of histopathology trace back to the 17th century with the development of microscopes by scientists like , enabling the first observations of cellular structures. By the late 18th century, Marie François Xavier Bichat established as a discipline by systematically classifying tissues, laying the groundwork for pathological applications in the through the work of , who emphasized cellular pathology. Today, , , and have enhanced precision, integrating molecular markers for more targeted diagnostics (as of 2025).

Definition and Scope

Definition

Histopathology is the microscopic examination of tissue sections to study the manifestations of disease, focusing on the observation of normal and abnormal cellular architecture. Tissue specimens, obtained from biopsies or surgical resections, are processed into thin slices typically 4-5 micrometers thick, mounted on glass slides, and stained with dyes such as hematoxylin and eosin to enhance contrast and visibility of cellular details. These stained slides are then viewed under light microscopy to identify pathological changes at the cellular and tissue levels. At its core, histopathology relies on the integration of microscopic observations with gross findings—such as the visible appearance of organs or tissues—and clinical data, including symptoms, results, and tests. This correlative approach enables pathologists to diagnose diseases by linking structural alterations in tissues to underlying etiologies, commonly applied to conditions like cancer (e.g., identifying malignant ), infections (e.g., detecting microbial or inflammatory infiltrates), and inflammatory disorders (e.g., assessing patterns of immune cell accumulation). Such synthesis is essential for accurate disease classification and guides therapeutic decisions in multidisciplinary clinical settings. Unlike cytology, which involves the analysis of individual cells suspended in fluids, smears, or fine-needle aspirates to detect abnormalities in cellular morphology, histopathology emphasizes the examination of intact, fixed, and sectioned tissue structures for routine diagnostic evaluation. It also differs from autopsy pathology, a subspecialty focused on post-mortem analysis of whole organs or the entire body to determine causes of death, whereas histopathology primarily addresses tissues from living patients. In the broader context of pathology, histopathology provides critical diagnostic insights that inform clinical management.

Historical Development

The foundations of histopathology were laid in the 17th century with advancements in microscopy that enabled the visualization of tissues at a cellular level. Antonie van Leeuwenhoek, a Dutch scientist, significantly advanced the microscope in the 1670s by crafting single-lens instruments that allowed for the first detailed observations of microscopic structures, including cells and microorganisms, marking a pivotal step toward tissue analysis. Concurrently, Marcello Malpighi, an Italian physician, pioneered tissue sectioning techniques in the 1660s, using early microscopes to examine thin slices of organs such as frog lungs, thereby establishing the basis for histological study through prepared specimens. The 19th century brought transformative innovations that made histopathology a practical discipline for disease investigation. , a German pathologist, introduced the theory of cellular pathology in 1858 through a series of lectures, positing that diseases arise from abnormalities in cells rather than humors, thus linking directly to pathological processes and founding modern histopathology. Building on this, Edwin Klebs developed paraffin embedding in 1869, a method that preserved tissues in wax for serial sectioning, facilitating more reliable microscopic examinations. In the 1880s, advanced staining techniques using coal tar dyes, which differentiated cellular components like granulocytes in blood and tissues, enabling routine identification of pathological changes. The 20th century solidified histopathology's role in clinical practice through procedural and institutional developments. Louis B. Wilson introduced frozen section techniques in the early 1900s at the , allowing rapid intraoperative tissue diagnosis by freezing and sectioning specimens without embedding, which revolutionized surgical decision-making. Following , histopathology emerged as a distinct , driven by expanded infrastructure and increased demand for precise tissue-based diagnostics in hospitals worldwide.

Role in Medicine

Diagnostic Applications

Histopathology serves as the gold standard for confirming clinical diagnoses by examining microscopic tissue patterns, particularly in distinguishing malignancies such as carcinomas, which originate from epithelial cells and exhibit glandular or squamous differentiation, from sarcomas, which arise from mesenchymal tissues and display spindle cell or pleomorphic features. In infectious diseases, it identifies characteristic structures like caseating granulomas in , consisting of epithelioid macrophages, Langhans giant cells, and central necrosis, enabling definitive diagnosis when microbiological tests are inconclusive. For autoimmune conditions, histopathology reveals interface hepatitis with lymphoplasmacytic infiltrates and rosette formation in , supporting diagnosis alongside serological markers. In clinical workflows, histopathology integrates with imaging modalities such as or CT to guide biopsies, achieving 90-95% accuracy in targeting suspicious lesions while minimizing invasiveness, followed by rapid reporting that directly informs treatment choices like neoadjuvant or surgical resection. This process ensures histopathological findings correlate with radiographic features, reducing diagnostic delays and enabling personalized care. Limitations include sampling errors, where underestimation of malignancy occurs in up to 20-30% of breast core needle biopsies due to heterogeneous tumor sampling, necessitating repeat procedures in ambiguous cases. Accuracy in cancer diagnosis varies by site but is generally high; for breast cancer via core needle biopsy, histopathology yields a sensitivity of 94.2% and specificity of 88.1%, with positive predictive value of 84.8% and negative predictive value of 95.6%. Globally, histopathology underpins the (WHO) tumor classifications, providing morphological criteria for standardized tumor typing and grading that facilitate international consistency in and therapy selection. It is also mandatory in reports per () guidelines, requiring inclusion of pathologic , gross and microscopic descriptions, and tumor extent to ensure complete for patient management.

Research and Prognostic Uses

Histopathology plays a crucial role in prognostic assessment by enabling the evaluation of tumor characteristics that predict disease progression and patient outcomes. One seminal example is the for , developed by Donald Gleason in the 1960s and refined in 1974, which assigns scores from 6 to 10 based on the architectural patterns of glandular structures in or resection specimens, with higher scores indicating more aggressive disease and influencing treatment decisions such as active surveillance versus radical therapy. This system has been widely adopted due to its correlation with risk and survival rates, providing pathologists with a standardized method to guide clinical management. In research, histopathology facilitates the investigation of disease mechanisms by offering detailed morphological insights into pathological processes. For instance, in studies, histopathological examination using special stains like or reveals —extracellular aggregates of β-amyloid peptides that are a defining feature of the disease and contribute to neuronal damage—allowing researchers to correlate plaque distribution and density with cognitive decline. Additionally, histopathology is integral to preclinical , where analysis of tissues from animal models provides morphologic context to biochemical and molecular data, assessing drug efficacy, toxicity, and off-target effects in contexts like or . Emerging applications of histopathology extend to tissue biobanking for genomic research and , where preserved specimens undergo histopathological validation to confirm molecular alterations identified through sequencing or . In digital biobanks, histopathological integrates with genomic and profiles to enable precise subtype of diseases like cancer, supporting tailored therapies based on individual tumor and . This approach has accelerated discoveries in precision oncology by linking histological patterns to actionable . A notable example of histopathology's impact is its role in elucidating ; studies from 2020 consistently identified as the predominant finding, characterized by membranes, alveolar , and type II pneumocyte , which informed understanding of the virus's acute respiratory effects and guided therapeutic strategies.

Specimen Collection

Types of Specimens

In histopathology, specimens are broadly categorized based on their origin and clinical context, primarily including , surgical resections, tissues, and select cytology-derived samples processed for histological analysis. These categories reflect the diverse sources from which tissue is obtained for microscopic examination to aid in , staging, and research. Biopsies represent small tissue samples acquired to investigate suspected abnormalities, with common subtypes including needle core biopsies, endoscopic biopsies, and excisional biopsies. Needle core biopsies, often used for accessible lesions such as lumps, involve a larger needle to extract cylindrical tissue cores for detailed architectural assessment. Endoscopic biopsies, typically obtained during procedures like , target mucosal abnormalities such as colon polyps to evaluate for or . Excisional biopsies entail the complete removal of a , providing comprehensive sampling for both diagnostic and therapeutic purposes. Surgical specimens encompass larger tissue samples removed during operative procedures, such as resection pieces and lymph nodes for . Resection specimens, like those from , include entire organs or significant portions to assess margins, tumor extent, and multifocality. Lymph nodes, sampled during procedures like , are critical for determining metastatic spread in cancers such as or . Autopsy tissues, derived from post-mortem examinations, provide samples for investigating causes of death, disease progression, or unexpected findings, often including organs like the heart, lungs, or brain. These specimens contribute to histopathological confirmation of clinical suspicions and epidemiological insights. Other sources include fine-needle aspirates processed as cell blocks for histological evaluation, particularly when cytological material is centrifuged and embedded to yield tissue-like sections for immunohistochemical or molecular studies. Specimens are distinguished by whether they originate from tumor or non-tumor tissues, influencing diagnostic focus; for instance, punch biopsies, which remove full-thickness cylindrical samples via a specialized tool, are commonly used in to assess inflammatory or neoplastic skin conditions. Proper handling protocols, as outlined in dedicated guidelines, ensure specimen integrity prior to processing.

Collection and Handling Methods

In histopathology, the collection and initial handling of tissue specimens are critical steps to ensure the preservation of cellular and molecular integrity for accurate diagnostic analysis. These procedures vary depending on whether the specimen is obtained via or surgical resection, with the primary goal of minimizing autolysis, , and structural distortion from the moment of acquisition. Proper handling begins at the point of collection in clinical or surgical settings, where immediate measures are taken to orient, document, and protect the sample. Biopsy techniques commonly employed in histopathology include for cytology and core needle biopsies for obtaining intact tissue cylinders, often facilitated by or automated biopsy guns to penetrate target lesions with precision. For core biopsies, a —a hollow outer needle with a beveled edge—guides the inner cutting needle to extract a cylindrical core of tissue, typically 1-2 mm in , which is essential for evaluating architectural features in organs such as or . To maintain spatial orientation, especially for assessing margins in potential malignancies, biopsies are marked with inks or dyes immediately after extraction; for instance, different colored inks can denote specific surfaces like anterior, posterior, or lateral edges, aiding pathologists in correlating microscopic findings with the original anatomical context. Surgical handling of resection specimens involves prompt gross examination by the or pathologist to identify key features such as tumor size, location, and involvement of margins, followed by systematic inking of the entire resection surface to demarcate surgical edges and detect microscopic tumor extension. Representative sections are then selected and submitted for processing; for example, in resections, multiple cross-sections from the tumor and adjacent normal tissue are chosen to avoid sampling artifacts like uneven fixation or loss of orientation, ensuring comprehensive histopathological evaluation. This step is performed under sterile conditions to prevent microbial contamination, with tools like scalpels and handled meticulously to preserve tissue integrity. Transport protocols emphasize rapid transfer to prevent degradation, often using fixative transport media such as 10% neutral buffered formalin for routine diagnostics, which stabilizes proteins and halts enzymatic activity upon immersion. Time-sensitive handling is paramount; for research applications involving molecular analyses like sequencing, specimens should be fixed within 30 minutes of collection to optimize preservation, as delays beyond this threshold can lead to RNA fragmentation and reduced yield. Specimens are typically placed in leak-proof containers labeled with patient details, collection date, and site, and transported at ambient temperature for formalin-fixed samples or on ice for fresh tissues requiring minimal processing. Safety measures during collection and handling prioritize sterile techniques and biohazard precautions, particularly for tissues from patients with infectious diseases such as or . All procedures adhere to , including the use of (gloves, gowns, masks), sharps disposal, and segregation of potentially contaminated materials in biohazard bags to mitigate transmission risks to healthcare personnel. In cases of suspected prions or high-containment pathogens, additional protocols like autoclaving or of waste are implemented per institutional guidelines.

Tissue Preparation

Fixation

Fixation is the initial step in tissue preparation for histopathology, aimed at stabilizing biological tissues by halting enzymatic degradation and preserving structural immediately after collection. The primary purpose is to proteins through chemical reactions, preventing autolysis (self-digestion by endogenous enzymes) and while maintaining cellular architecture and antigens for subsequent diagnostic and analysis. The most widely used fixative is 10% neutral buffered formalin, a 4% solution in buffer at pH 7, which penetrates tissues at approximately 1 mm per hour and forms methylene bridges between reactive amino groups on proteins such as and , creating stable cross-links that rigidify the tissue matrix. For electron microscopy, (typically 2-2.5% in ) serves as an alternative or primary fixative, offering superior ultrastructural preservation through extensive intra- and intermolecular protein cross-linking, though it penetrates more slowly and is often followed by secondary osmication. Optimal fixation parameters are crucial to balance preservation and avoid distortion; formalin-fixed tissues are generally immersed in fixative at a 20:1 to 25:1 volume ratio relative to tissue size, with agitation to ensure uniform penetration, at room temperature (around 21-25°C) for 24-48 hours to allow complete initial cross-linking without excessive hardening. Under-fixation (less than 6-24 hours) risks incomplete stabilization leading to autolytic artifacts like nuclear fading, while over-fixation (beyond 48 hours) can cause tissue shrinkage up to 30% and mask antigens, reducing immunoreactivity in immunohistochemical assays. A common artifact is formalin , which forms as dark brown, birefringent crystalline deposits in acidic conditions ( below 6) or in hemoglobin-rich tissues like or hemorrhagic areas, resulting from the reaction of with groups. This can be removed by immersing sections in saturated alcoholic for 15 minutes to overnight or in ammonia-alcohol solution for 10 minutes prior to staining, followed by thorough washing to prevent interference with microscopic interpretation.

Processing and Embedding

After fixation, tissue processing prepares specimens for embedding by removing water and replacing it with a supportive medium, ensuring structural integrity for subsequent sectioning. This multistep procedure—dehydration, clearing, and infiltration—minimizes distortion and artifacts while facilitating paraffin wax integration. Dehydration removes water from fixed tissues using a sequential gradient of ethanol solutions, typically progressing from 70% to 100% concentrations, to prevent incomplete removal that could trap moisture and cause bubble artifacts or opacity in sections. This graded approach, often involving multiple changes at each concentration (e.g., 1.5 hours in 70% ethanol, followed by two 1.5-hour immersions in 95% and three in 100%), minimizes tissue shrinkage and distortion through controlled solvent exchange. Clearing follows dehydration by displacing with an organic solvent that renders the tissue transparent and miscible with paraffin, such as or less toxic substitutes like . Agents like require 2–4 changes (e.g., one hour in a 50:50 - mix, followed by two one-hour immersions) to effectively remove and ensure uniform penetration, with agitation enhancing efficiency. Infiltration impregnates the cleared tissue with molten ( 56–60°C), typically via 2–3 changes (e.g., two one-hour immersions), often under to remove air and promote even distribution for during sectioning. then molds the infiltrated tissue into paraffin blocks using embedding stations, where it is oriented and cooled (e.g., at 4°C for 15 minutes) to solidify into durable blocks suitable for microtomy. These steps are commonly automated using tissue processors that cycle through over 12–16 hours, incorporating agitation and controlled temperatures to ensure uniform , clearing, and paraffin penetration across multiple specimens.

Sectioning Techniques

Paraffin Sectioning

Paraffin sectioning is the standard technique for producing thin, high-quality tissue sections from paraffin-embedded blocks, enabling detailed microscopic examination in routine histopathology diagnostics. This method involves using a rotary to slice the embedded tissue into ribbons of sections, which are then mounted onto slides for subsequent processing. The process ensures preservation of morphological details while allowing serial sectioning for comprehensive analysis. Rotary microtomes are employed to generate sections typically 4-5 micrometers thick, optimal for routine histopathological evaluation as they balance detail resolution with ease of handling. The paraffin block, prepared through prior and , is securely clamped into the microtome's specimen holder, with the face trimmed to expose the tissue surface. Disposable s are inserted into the blade holder, and the clearance angle—usually set between 3-8 degrees—is adjusted to ensure clean cuts by preventing the blade from dragging on the section. Sectioning proceeds with slow, even advancement of the handwheel, producing uniform slices without excessive force. Once cut, sections are floated on a warm water bath at 40-45°C to flatten and remove wrinkles caused by compression during cutting. The bath's is critical: too low prevents expansion, while too high risks tissue . Sections are gently maneuvered with a to unfold completely before being picked up onto charged slides, which promote adhesion. This mounting step, often performed in a serial manner, ensures sections dry evenly for archival stability. The ing technique facilitates efficient serial sectioning by producing connected strips of multiple sections (typically 4-6 per ), which can be transferred en masse to the water bath or adhesive-coated strips for orientation tracking. To achieve straight , the block's edges are chamfered into a shape prior to cutting, minimizing curling; a soft guides the away from the blade if occurs. This method supports by allowing comparison across consecutive levels. Common challenges in paraffin sectioning include variations in section thickness and chatter marks, which manifest as parallel lines from blade vibration. Thick or thin sections often result from improper blade tilt, excessive speed, or loose microtome components, and can be resolved by increasing the tilt angle slightly, maintaining moderate cutting speed, and tightening all fixtures. Chatter marks, particularly in dense tissues, are mitigated through block face trimming to reduce hardness gradients, replacement if dull, and application of such as anti-roll fluids on the blade edge. Proper block preparation from minimizes these issues overall.

Frozen Section Processing

Frozen section processing is a rapid tissue preparation technique employed in histopathology for intraoperative consultations, enabling pathologists to provide preliminary diagnoses during surgical procedures. This method involves quick freezing of fresh tissue specimens to preserve cellular architecture for immediate sectioning and microscopic examination, contrasting with the more deliberate routine paraffin methods detailed in the Paraffin Sectioning section. The freezing process begins with the placement of unfixed tissue into a cryomold filled with Optimal Cutting Temperature (OCT) embedding medium, a water-soluble compound that supports the tissue without introducing artifacts during cryosectioning. The mold is then positioned on a pre-chilled chuck, often cooled to -20°C to -30°C within the cryostat chamber, and snap-frozen using liquid nitrogen or a similar cryogen for 10-30 seconds to minimize ice crystal formation. Once frozen, the embedded tissue block is mounted in a , a specialized low-temperature maintained at -20°C to -30°C, where a cryomicrotome blade cuts sections typically 5-10 micrometers thick. These sections are transferred directly onto glass slides, bypassing and clearing steps used in paraffin processing, and are immediately available for , such as hematoxylin and eosin, to facilitate rapid evaluation. A key advantage of frozen section processing is its speed, allowing for diagnostic results within 20-30 minutes from specimen receipt, which is critical for intraoperative decisions like assessing surgical margins in tumor resections. However, the technique has limitations, including suboptimal tissue morphology due to ice crystal artifacts that can distort cellular details and architecture. Additionally, frozen sections exhibit a diagnostic error rate of approximately 1-2% when compared to permanent paraffin sections, primarily arising from sampling, technical, or interpretive challenges.

Staining Methods

Routine Stains

Routine stains in histopathology provide essential contrast to visualize general tissue architecture and cellular details in paraffin-embedded sections, serving as the foundation for most diagnostic evaluations. The most widely used routine stain is hematoxylin and eosin (H&E), which differentially colors nucleic acids and proteins to highlight basophilic (acid-loving) and acidophilic (base-loving) components of tissues. Hematoxylin, derived from the logwood tree, acts as a basic dye that binds to acidic structures like and in cell nuclei, imparting a blue-violet hue, while , an acidic , stains cytoplasmic proteins, , and in shades of pink to red. This combination allows pathologists to assess morphology without targeting specific molecules, making H&E indispensable for routine diagnostics. The H&E staining protocol follows a standardized sequence to ensure reproducibility across laboratories. Sections are first dewaxed in to remove embedding medium, followed by rehydration through graded alcohols to water. Tissues are then immersed in hematoxylin solution for 5-10 minutes, depending on the formulation, to achieve nuclear staining; this can be progressive (gradual buildup until desired intensity) or regressive (overstaining followed by differentiation in acid to remove excess dye). Bluing follows in an alkaline solution like ammonia water or Scott's substitute for 1-5 minutes to convert the initial red hematoxylin-lake complex to the stable blue form. counterstaining occurs next for 30 seconds to 2 minutes, adjusted for tissue type, before dehydration in ascending alcohols, clearing in , and mounting under a coverslip with resinous medium. These steps, typically automated in high-volume labs, yield slides ready for light microscopy within 30-60 minutes post-sectioning. H&E is the default stain for approximately 95% of slides, enabling visualization of tissue organization, cell types, and pathological changes in virtually all specimens, from biopsies to resections. Its universal application stems from the broad-spectrum contrast it provides, revealing architectural patterns like glandular formations or stromal without additional . Variations in protocol optimize results for specific tissues; for instance, shorter eosin exposure (10-30 seconds) prevents over-staining in fatty tissues such as adipose or liver, while longer hematoxylin times enhance nuclear detail in densely cellular samples like lymphomas. Adjustments may also include mordants like aluminum salts to intensify hematoxylin binding, ensuring consistency across diverse clinical scenarios.

Special and Histochemical Stains

Special and histochemical stains in histopathology are targeted chemical techniques designed to selectively highlight specific tissue components, such as carbohydrates, connective tissues, pathogens, or extracellular deposits, providing diagnostic insights beyond the general contrast offered by routine hematoxylin and eosin (H&E) . These methods rely on the differential affinity of dyes or reagents for particular molecular structures, enabling pathologists to visualize subtle features like , infections, or protein aggregates that may be inconspicuous in standard preparations. Histochemical stains, in particular, exploit biochemical reactions to detect macromolecules, while special stains often focus on microbial elements or fibrous architectures. The Periodic Acid-Schiff () stain is a widely used histochemical method that detects , including and mucins, by oxidizing vicinal diols in these molecules with periodic acid to form aldehydes, which then react with Schiff's reagent to produce a color. In histopathology, PAS is valuable for identifying fungal infections, basement membranes in renal biopsies, and glycogen storage diseases, where digestion can differentiate (which is removed) from other PAS-positive structures like mucins in adenocarcinomas. Applications include assessing liver in metabolic disorders and highlighting mucins in gastrointestinal pathologies. Masson's trichrome stain differentiates fibers from cellular elements by employing a mixture of dyes—typically Weigert's iron hematoxylin for nuclei (black), Biebrich scarlet-acid fuchsin for and muscle (red), and aniline blue or light green for (blue)—with the acidic environment preferentially binding the blue dye to due to its high affinity for groups. This stain is essential for evaluating in liver , cardiac , and pulmonary interstitial diseases, where increased blue-staining quantifies the extent of fibrotic replacement of parenchymal tissue. In renal , it aids in distinguishing sclerotic glomeruli from normal structures. Special stains for pathogens, such as the , classify based on properties: gram-positive organisms retain crystal violet-iodine complexes (appearing purple) after alcohol decolorization, while gram-negative ones lose it and counterstain pink with , allowing identification of infections like staphylococcal abscesses or E. coli in tissue sections. The Ziehl-Neelsen (ZN) stain targets acid-fast , such as , by using heated that penetrates lipid-rich cell walls, resisting decolorization with acid-alcohol and appearing red against a blue methylene counterstain, crucial for diagnosing in biopsies where may be sparse. These stains enhance detection of microbial colonies that appear nonspecific on H&E. Reticulin stains, employing silver impregnation methods like Gomori's technique, visualize type III fibers in reticular frameworks by reducing silver ions onto argyrophilic fibers after sensitization with nitrate or similar agents, resulting in black threads against a background that outline hepatic sinusoids, splenic architecture, or tumor invasion patterns in lymphomas. The mechanism involves the selective deposition of metallic silver on reticulin without requiring enzymatic digestion, providing a clear view of supportive stroma in biopsies for assessing myelofibrosis. In applications for extracellular deposits, the Congo red stain identifies amyloid by binding to beta-pleated sheet structures in fibrils, appearing salmon-pink under brightfield and exhibiting pathognomonic apple-green birefringence under polarized light due to the dye's anisotropic alignment with amyloid's ordered conformation. This is diagnostic for systemic amyloidosis in tissues like kidney or heart, distinguishing it from hyaline or collagenous deposits, and is confirmed by the potassium permanganate pretreatment test, where AA amyloid is sensitive (Congo red staining is lost after treatment), while AL amyloid is resistant (staining retained).

Microscopic Interpretation

Architectural Patterns

Architectural patterns in histopathology refer to the overall organization and spatial arrangement of tissue components observed under the , which provide critical insights into the nature and behavior of pathological processes, particularly in neoplasms. These patterns are evaluated at low to medium to assess how cells and extracellular elements form structures, distinguishing benign from malignant conditions and aiding in tumor and grading. In epithelial malignancies, such as adenocarcinomas, the preservation or disruption of glandular is a key diagnostic feature, while in mesenchymal or hematopoietic tumors, stromal or inflammatory arrangements offer prognostic clues. Glandular patterns are prominent in adenocarcinomas, where neoplastic cells form organized structures mimicking normal glandular . Tubular patterns consist of simple or complex elongated ducts lined by a single or double layer of cuboidal to columnar cells, often seen in well-differentiated colorectal or adenocarcinomas, reflecting partial retention of ductal differentiation. Papillary patterns feature fibrovascular cores lined by epithelial cells, projecting into cystic spaces, as commonly observed in papillary or serous ovarian tumors, where the architecture supports invasion along fronds. Cribriform patterns, characterized by sieve-like sheets with multiple punched-out lumina, indicate intermediate differentiation and are hallmark in acinar adenocarcinoma or tumors, correlating with higher Gleason scores in . In contrast, undifferentiated tumors exhibit solid sheets of cells with loss of glandular formation, appearing as back-to-back nests without lumina, as in high-grade sarcomatoid or anaplastic variants, signifying aggressive and poor . Stromal interactions, particularly , represent a fibrotic host response to invasive cancers, where dense deposition encases tumor nests. arises from activation of cancer-associated fibroblasts producing , forming a sclerotic barrier that facilitates tumor progression in pancreatic ductal or invasive . This reaction is quantified histologically by assessing the proportion of fibrotic stroma relative to tumor cellularity, often using semi-quantitative scales such as the desmoplastic reaction classification (mature, intermediate, or immature) in , where immature with myxoid features predicts worse survival. In grading systems, extensive contributes to higher scores, as in the grading for , where stromal elicits marked , impacting therapeutic response. Computer-assisted image analysis has been employed to measure desmoplastic extent objectively, reporting stromal fraction as a percentage, with values exceeding 50% indicating advanced in xenografts. Inflammatory architecture in lymphomas highlights the distribution of lymphoid cells, distinguishing organized from chaotic growth. Follicular patterns in mimic reactive germinal centers, with neoplastic B-cells forming expanded, irregularly shaped follicles that back-to-back crowd the node, often with attenuated mantles and lack of polarization, as defined in WHO classifications. Diffuse patterns, prevalent in , show effacement of nodal architecture by sheets of large cells without follicular remnants, leading to a star-sky appearance due to interspersed macrophages. The transition from follicular to diffuse growth in transformed lymphomas indicates progression and is assessed by the proportion of diffuse areas, with >50% diffuse component worsening . These patterns are evaluated on low-power views to confirm architecture before immunoarchitectural correlation. Quantitative assessment of architectural patterns often incorporates the as a proliferation marker, calculated by counting mitotic figures in the most active tumor areas. The standard method involves tallying mitoses per 10 high-power fields (HPF, typically 0.196 mm² at 40x ) under conventional , with thresholds such as >15 mitoses/10 HPF (or >15 in 2 mm²) for mitotic score 3, contributing to high-grade (grade 3) tumors in per Nottingham criteria. This index reflects proliferative activity within the tissue architecture, aiding grading in sarcomas or neuroblastomas, where elevated counts (>20/10 HPF) correlate with aggressive behavior independent of other features. Standardization of field area is crucial, as variations in can alter counts by up to 30%, emphasizing the need for calibrated in reporting.

Cellular and Nuclear Features

In histopathology, the analysis of nuclear features plays a pivotal role in diagnosing , as alterations in nuclear morphology often reflect dysregulated cell growth and genetic instability. Nuclear pleomorphism, defined by significant variation in nuclear size and shape among cells within a , is a classic indicator of neoplastic transformation across various cancer types. This irregularity arises from chromosomal aberrations and is readily observable under light microscopy in hematoxylin and eosin- sections. , characterized by darkly nuclei due to increased density, further signals rapid and is commonly associated with aggressive tumors. Prominent nucleoli, enlarged and intensely basophilic structures within the nucleus, denote elevated synthesis to support heightened metabolic demands in malignant cells. These features—pleomorphism, hyperchromasia, and conspicuous nucleoli—collectively aid pathologists in distinguishing malignant from benign lesions, with their presence correlating strongly with poor prognosis in many carcinomas. Cytoplasmic alterations provide complementary insights into cellular , often highlighting metabolic or infectious processes. appears as clear, membrane-bound spaces within the , frequently resulting from lipid accumulation in storage disorders such as Niemann-Pick disease, a lysosomal storage condition where buildup leads to foamy or vacuolated cells in affected tissues like the and liver. In viral infections, cytoplasmic inclusions—dense, pink-staining aggregates—may form due to viral protein synthesis or cellular response, as seen in herpesvirus infections where these inclusions contribute to cytopathic effects in epithelial cells. Such changes help differentiate degenerative processes from neoplastic ones, emphasizing the 's role in revealing underlying disease mechanisms. Identifying specific cell types is fundamental to accurate histopathological interpretation, particularly in tumors where lineage determination influences and . Epithelial cells are typically cohesive, exhibiting cell-to-cell via junctions and often displaying polarity with basal nuclei and apical surfaces, forming glandular or sheet-like structures in tissues. In contrast, mesenchymal cells lack this cohesion, appearing as individual, elongated spindle-shaped elements embedded in , which is evident in sarcomas or stromal components. mitoses, marked by aberrant spindle formation, asymmetric distribution, or divisions, represent a hallmark of , reflecting genomic chaos and distinguishing cancerous proliferation from physiologic renewal. These mitotic abnormalities are quantified in grading systems to assess tumor aggressiveness. One prominent application of these cellular and nuclear assessments is the histological grading system for invasive breast carcinoma, which evaluates tumor behavior through three criteria: tubule formation (assessing architectural differentiation), nuclear pleomorphism (gauging size and shape variation), and mitotic count (enumerating divisions per ). Each component is scored from 1 (most differentiated) to 3 (least differentiated), with the sum yielding a total grade of 1 to 3, where higher scores predict worse outcomes and guide decisions. This system, refined for reproducibility, integrates nuclear features directly into prognostic stratification.

Advanced Techniques

Immunohistochemistry

Immunohistochemistry (IHC) is a technique that leverages the specific binding of antibodies to s for detecting and localizing proteins within tissue sections, enabling precise identification of cellular components in histopathology. Primary antibodies, raised against target s, are applied to formalin-fixed paraffin-embedded (FFPE) tissue sections, where they bind selectively to epitopes on proteins of interest. This binding is amplified and visualized using secondary detection systems, such as -linked antibodies—commonly (HRP)—that catalyze a chromogenic substrate like (DAB), producing a visible precipitate at the site of localization under light microscopy. Polymer-based detection methods further enhance sensitivity by incorporating multiple molecules on a polymeric backbone, reducing background noise and improving signal intensity. Standard IHC protocols begin with deparaffinization and rehydration of FFPE sections, followed by retrieval to reverse fixation-induced protein cross-linking that masks epitopes. Heat-induced retrieval (HIAR), often performed using microwaves, water baths, or pressure cookers in buffers like citrate (pH 6.0) at temperatures around 95–100°C for 10–30 minutes, is the most widely adopted method, applicable to the majority of . Enzymatic retrieval with proteinases such as or serves as an alternative for heat-sensitive targets, though it risks over-digestion. Post-retrieval, endogenous is blocked with to prevent non-specific staining, and non-specific binding is minimized using serum or protein blockers. Incubation with primary and secondary occurs at optimized dilutions and times, typically 30–60 minutes at or overnight at 4°C, followed by development and counterstaining with hematoxylin. Specificity is validated through positive controls (tissues known to express the ) and negative controls (omitting the primary or using isotype controls) in every run. In diagnostic histopathology, IHC panels are selected based on differential diagnoses, employing antibodies against lineage-specific markers to classify tumors. Cytokeratins (e.g., AE1/AE3 cocktail) form a cornerstone panel for confirming epithelial differentiation in carcinomas, distinguishing them from mesenchymal or hematopoietic neoplasms by demonstrating cytoplasmic staining. For hematolymphoid malignancies, panels incorporate (CD) markers, such as , a B-cell-specific that shows strong membranous expression in most B-lymphocyte lymphomas, aiding in their identification and subtyping. These panels are often combined with other markers like CD3 for T-cells or CD45 for leukocytes to provide a comprehensive immunophenotype. Key applications of IHC include predictive and prognostic testing in , where it guides therapeutic decisions. In , HER2 (human 2) IHC assesses membrane staining intensity and completeness, scored semiquantitatively from 0 (no staining) to 3+ (complete, intense circumferential staining in >10% of tumor cells), with scores of 3+ indicating overexpression suitable for anti-HER2 therapies like , while 2+ cases require reflex (FISH) confirmation. Similarly, IHC for (MMR) proteins—MLH1, MSH2, MSH6, and PMS2—evaluates nuclear expression in colorectal and other tumors; loss of one or more proteins (e.g., isolated PMS2 loss) signals potential and prompts testing for Lynch , a hereditary condition increasing cancer risk. These applications underscore IHC's role in , with standardized protocols ensuring reproducibility across laboratories.

Digital and Molecular Integration

Digital pathology has revolutionized histopathological analysis by enabling the digitization of entire glass slides into high-resolution virtual images, typically at 40x magnification, which facilitates remote consultations and integration with computational tools. Whole-slide imaging (WSI) scanners, such as those from ' Aperio series and Roche's Digital Pathology Dx system, capture detailed gigapixel images that allow pathologists to review specimens without physical slides, supporting applications in telemedicine and . These systems have demonstrated noninferiority to traditional for primary diagnosis, with diagnostic concordance rates exceeding 95% in clinical settings. AI-assisted on WSI further enhances efficiency by automating feature detection, reducing interobserver variability in tumor identification. Molecular integration in histopathology combines traditional morphological assessment with genetic techniques to provide prognostic and therapeutic insights. (FISH) is a key method for detecting gene amplifications, such as HER2 in , where amplification is defined by a HER2/CEP17 ratio greater than 2.0, indicating eligibility for targeted therapies like . This ratio, assessed on nuclei within histological sections, correlates strongly with clinical outcomes, with amplified cases showing aggressive tumor behavior. Next-generation sequencing (NGS) complements this by correlating genomic alterations, such as TP53 mutations, with histological grades; for instance, high-grade carcinomas often exhibit higher mutational burdens that align with Nottingham grading scores, aiding in personalized treatment stratification. Artificial intelligence applications in histopathology leverage to automate quantitative tasks, improving accuracy and reproducibility. Algorithms for mitotic counting in , a critical component of tumor grading, achieve accuracies over 90% compared to manual methods, significantly reducing pathologist workload while maintaining diagnostic reliability. These models, trained on annotated whole-slide images, identify mitotic figures with precision that surpasses human interobserver agreement in high-volume settings. In analysis, AI quantifies spatial relationships between immune cells, stroma, and cancer cells, revealing immunosuppressive patterns that predict response; for example, convolutional neural networks can segment infiltration with sensitivities above 85%, informing expression correlations. Emerging trends in histopathology emphasize global accessibility and multimodal visualization. Telepathology networks enable real-time diagnostic consultations across regions, particularly in underserved areas, with systems achieving diagnostic accuracies of 96-97% for frozen sections and supporting collaborative cancer diagnostics in . Multiplex immunohistochemistry (mIHC) advances marker assessment by allowing simultaneous visualization of up to nine proteins on a single tissue section, using tyramide signal amplification to preserve spatial context and enhance understanding of heterogeneous tumor microenvironments. This technique, integrated with , facilitates high-throughput phenotyping for precision .

References

  1. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/histopathology
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC10031787/
  3. https://www.ncbi.nlm.nih.gov/books/NBK557663/
  4. https://pubmed.ncbi.nlm.nih.gov/33644816/
  5. https://hsrc.himmelfarb.gwu.edu/cgi/viewcontent.cgi?article=1095&context=smhs_anatregbio_facpubs
  6. https://pmc.ncbi.nlm.nih.gov/articles/PMC12576219/
  7. https://training.seer.cancer.gov/abstracting/procedures/pathological/
  8. https://www.rcpath.org/discover-pathology/news/fact-sheets/histopathology.html
  9. https://www.va.gov/vdl/documents/Clinical/Lab-Anatomic_Pathology/lab_ap_lr_5_2_ug.pdf
  10. https://imhm.org/page-1855113
  11. https://histology.siu.edu/milestones.htm
  12. https://www.biodiversitylibrary.org/bibliography/110759
  13. https://pmc.ncbi.nlm.nih.gov/articles/PMC8571243/
  14. https://journals.asm.org/doi/10.1128/microbiolspec.mchd-0032-2016
  15. https://meridian.allenpress.com/aplm/article/129/12/1532/459416/The-Centennial-Anniversary-of-the-Frozen-Section
  16. https://annals.edu.sg/happenings-in-histopathology-a-post-world-war-ii-perspective/
  17. https://training.seer.cancer.gov/disease/categories/classification.html
  18. https://pmc.ncbi.nlm.nih.gov/articles/PMC10035589/
  19. https://pmc.ncbi.nlm.nih.gov/articles/PMC8241564/
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC6592078/
  21. https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.22435
  22. https://pubmed.ncbi.nlm.nih.gov/16823506/
  23. https://tumourclassification.iarc.who.int/
  24. https://meridian.allenpress.com/aplm/article/132/10/1608/460339/Reporting-Guidelines-for-Clinical-Laboratory
  25. https://pubmed.ncbi.nlm.nih.gov/22212079/
  26. https://www.nature.com/articles/modpathol2017133
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC4779758/
  28. https://pmc.ncbi.nlm.nih.gov/articles/PMC7745791/
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC2813509/
  30. https://pmc.ncbi.nlm.nih.gov/articles/PMC6927822/
  31. https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-04891-8
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC4705034/
  33. https://www.nature.com/articles/s41379-020-00661-1
  34. https://www.cancer.org/cancer/diagnosis-staging/tests/biopsy-and-cytology-tests/biopsy-types.html
  35. https://www.mayoclinic.org/diseases-conditions/cancer/in-depth/biopsy/art-20043922
  36. https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/pathology-reports-fact-sheet
  37. https://onlinelibrary.wiley.com/doi/10.1111/his.14335
  38. https://pmc.ncbi.nlm.nih.gov/articles/PMC5492749/
  39. https://www.cancer.org/cancer/diagnosis-staging/tests/biopsy-and-cytology-tests/testing-biopsy-and-cytology-samples-for-cancer/how-samples-are-processed.html
  40. https://pmc.ncbi.nlm.nih.gov/articles/PMC3519217/
  41. https://pmc.ncbi.nlm.nih.gov/articles/PMC4240801/
  42. https://pmc.ncbi.nlm.nih.gov/articles/PMC2631091/
  43. https://www.ncbi.nlm.nih.gov/books/NBK599504/
  44. https://pmc.ncbi.nlm.nih.gov/articles/PMC4211218/
  45. https://www.urmc.rochester.edu/MediaLibraries/URMCMedia/urmc-labs/pathology/about-us/images/Method-of-Histochemical-Stains-Diagnostic-Application.pdf
  46. https://www.leicabiosystems.com/sites/default/files/media_document-file/2021-04/190093_Rev_A_Science_of_Tissue_Processing.pdf
  47. https://biomedpharmajournal.org/vol9no2/artifact-in-histological-section/
  48. https://cdn.dal.ca/content/dam/dalhousie/pdf/faculty/medicine/departments/department-sites/pathology/tissue%20processing%20protocol.pdf
  49. https://www.leicabiosystems.com/us/knowledge-pathway/an-introduction-to-specimen-processing/
  50. https://www.ihisto.io/tissue-processing/tissue-processing-and-embedding
  51. https://pmc.ncbi.nlm.nih.gov/articles/PMC6235097/
  52. https://www.bdbiosciences.com/en-us/resources/protocols/parafin-sections
  53. https://www.leicabiosystems.com/sites/default/files/media_document-file/2024-03/201295_Rev_A_Microtomy_and_Paraffin_Section_Preparation.pdf
  54. https://biomedizin.unibas.ch/fileadmin/user_upload/biomedizin/core_facilities/histology/Guides/Paraffin_methods.pdf
  55. https://anatomy-cellbiology.ecu.edu/wp-content/pv-uploads/sites/7/Paraffin-Sectioning-Instructions.pdf
  56. https://depts.washington.edu/rubelab/protocols/paraffin.html
  57. https://medequipsource.com/microtome-cutting-tips-how-can-i-resolve-thick-thin-sections/
  58. https://www.nsh.org/blogs/natalie-paskoski/2020/05/05/microtomy-troubleshooting-tips
  59. https://www.leicabiosystems.com/us/knowledge-pathway/the-art-of-embedding-tissue-for-frozen-section/
  60. https://www.rndsystems.com/resources/protocols/protocol-preparation-and-fluorescent-ihc-staining-frozen-tissue-sections
  61. https://www.feinberg.northwestern.edu/sites/mhpl/docs/tissue-freezing-presentation-5-26-20111.pdf
  62. https://pubmed.ncbi.nlm.nih.gov/9199619/
  63. https://news.mayocliniclabs.com/2018/03/27/frozen-and-on-time-rapid-margin-assessment-helps-prevent-repeat-surgeries/
  64. https://www.kfbiopathology.com/kfbio-digital-pathology/pathology-knowledge-how-intraoperative-rapid-frozen-section-helps-surgeons-make-decisions
  65. https://www.nature.com/articles/modpathol2010233
  66. https://pmc.ncbi.nlm.nih.gov/articles/PMC3347896/
  67. https://pubmed.ncbi.nlm.nih.gov/495695/
  68. https://pmc.ncbi.nlm.nih.gov/articles/PMC4065450/
  69. https://www.pathologyoutlines.com/topic/prostateprostaticduct.html
  70. https://librepathology.org/wiki/Morphologic_patterns
  71. https://www.researchgate.net/figure/Spectrum-of-histologic-patterns-in-pancreatic-ductal-adenocarcinomas-PDACs-A_fig1_313253481
  72. https://pmc.ncbi.nlm.nih.gov/articles/PMC8193706/
  73. https://pmc.ncbi.nlm.nih.gov/articles/PMC1770537/
  74. https://journals.lww.com/ajsp/fulltext/2019/09000/novel_internationally_verified_method_reports.9.aspx
  75. https://pmc.ncbi.nlm.nih.gov/articles/PMC2929284/
  76. https://www.pathologyoutlines.com/topic/lymphomadiffuse.html
  77. https://www.jpatholtm.org/upload/pdf/jptm_v56n1_full.pdf
  78. https://documents.cap.org/protocols/cp-breast-invasive-18protocol-4100.pdf
  79. https://pmc.ncbi.nlm.nih.gov/articles/PMC8376633/
  80. https://journals.sagepub.com/doi/10.1177/0300985815593349
  81. https://onlinelibrary.wiley.com/doi/10.1111/his.14542
  82. https://pmc.ncbi.nlm.nih.gov/articles/PMC9722227/
  83. https://pmc.ncbi.nlm.nih.gov/articles/PMC3809146/
  84. https://www.webpathology.com/images/pediatric/pediatric-pathology---i/inborn-errors-of-metabolism/58013
  85. https://pubmed.ncbi.nlm.nih.gov/20398595/
  86. https://eclinpath.com/cytology/cytology-interpretation/
  87. https://www.nature.com/articles/s41379-022-01080-0
  88. https://pmc.ncbi.nlm.nih.gov/articles/PMC6749998/
  89. https://pmc.ncbi.nlm.nih.gov/articles/PMC5122731/
  90. https://pmc.ncbi.nlm.nih.gov/articles/PMC3439132/
  91. https://pmc.ncbi.nlm.nih.gov/articles/PMC9057666/
  92. https://www.cap.org/protocols-and-guidelines/cap-guidelines/current-cap-guidelines/recommendations-for-human-epidermal-growth-factor-2-testing-in-breast-cancer
  93. https://meridian.allenpress.com/aplm/article/143/10/1225/420713/Screening-for-Lynch-Syndrome-by
  94. https://lumeadigital.com/the-10-best-digital-pathology-scanners/
  95. https://academic.oup.com/ajcp/article/164/3/367/8159195
  96. https://pmc.ncbi.nlm.nih.gov/articles/PMC12308189/
  97. https://www.sciencedirect.com/science/article/pii/S2153353922001729
  98. https://pmc.ncbi.nlm.nih.gov/articles/PMC3361866/
  99. https://www.mayocliniclabs.com/test-catalog/overview/65879
  100. https://onlinelibrary.wiley.com/doi/10.1111/his.14794
  101. https://www.nature.com/articles/s41523-022-00478-y
  102. https://pmc.ncbi.nlm.nih.gov/articles/PMC7335442/
  103. https://www.modernpathology.org/article/S0893-3952%2823%2900321-6/fulltext
  104. https://pmc.ncbi.nlm.nih.gov/articles/PMC10952145/
  105. https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-05609-6
  106. https://pmc.ncbi.nlm.nih.gov/articles/PMC11573928/
  107. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2022.978245/full
  108. https://pmc.ncbi.nlm.nih.gov/articles/PMC7170662/
  109. https://www.nature.com/articles/s41598-017-15798-4
Add your contribution
Related Hubs
User Avatar
No comments yet.